Horehound Supplements Sales Sustained by Regulatory Amendments Advocating their Effectiveness, finds FactMR Study
The study opines that adoption of the horehound supplements market remain sustained by highly effective marketing strategies that are centered on the invented idea that advocates the necessity of these products for maintaining good health. Amendments made to US Federal Food, Drug and Cosmetic Act exclude manufacturers from all regulations on OTC and prescription drugs. The FDA will be responsible, rather than the manufacturers, to claim effectiveness and safety of these products, which has dramatically favored adoption of botanical supplements, in turn complementing the horehound supplements sales.
Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=3564
The U.S. FDA has not approved horehound as an effective cough-suppressant, however the European Medicines Agency (EMA) as well as German Commission E have approved its use as expectorant and appetite stimulant, as the herb meets the criteria for ‘traditional use registration’ for non-prescription, herbal medicines. The study also finds that the clean-label motivations are permeating the supplements landscape, and growing consumer awareness has driven the shift away from medicines to nutrition supplements. The trend has paved lucrative avenues for horehound supplement manufacturers, acting as a key enabler of product differentiation.
North America Leads the Way in Horehound Supplements Landscape
According to the study, North America continues to remain the leading market for horehound supplements, with sales in 2018 estimated in excess of 1,700 tons. According to the American Botanical Council, horehound is one of the top-selling ingredients for botanical supplements, commonly used in cold and cough remedies owing to its relevant suppressant properties. This, coupled with macro trends that range from unprecedented adoption of natural health remedies to growing preference for organic and natural products, continue to underpin sales of horehound supplements in North America.
Browse Full Report on Horehound Supplements Market with In-depth TOC- https://www.factmr.com/report/3564/horehound-supplements-market
Asia Pacific Excluding Japan (APEJ) will continue to remain the high-growth market for horehound supplements. Growing health-conscious demographic in the region, along with a relatively larger consumer base, continue to underpin lucrativeness of the region for horehound supplement sales. These supplements have gained popularity as effective solutions to combat stress, apart from their attribute of being a rich source of antioxidants.
The study finds that consumer show a marked preference for liquid horehound supplements, which can be attributed in part to their easier mode of administration. Worldwide sales of liquid horehound supplements account for over 40% market shares.
The study finds that contribution of drug stores to horehound supplements sales remains high, accounting for approximately two-fifth shares in 2019. In addition to implementing new technologies in processes and operations for more economic extraction and production, horehound supplement manufacturers are adopting novel marketing techniques, including the leverage of online platforms, to expand their customer base.
FactMR’s study also offers a long-term forecast of the horehound supplements market for the period between 2019 and 2027. The horehound supplements market is projected to register a volume CAGR of 8.0% through 2027.
To Buy Horehound Supplements Market Report, Visit- https://www.factmr.com/checkout/3564/S
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Horehound Supplements Sales Sustained by Regulatory Amendments Advocating their Effectiveness, finds FactMR Study here
News-ID: 1743814 • Views: 209
More Releases from Fact.MR
Biobanking Market to Soar to US$ 3.5 Bn by 2027, Notes Fact.MR
Biobanks are a type of repository which is used in the storage of biological samples, including human and animal tissues, which primarily find use in research applications. Consequently, the process of biobanking has become a very important part of medical research and has played a major role in modern science fields such as personalized medications, and genomics. The global biobanking market is expected to grow at a healthy CAGR of ~
Mini LED Market to Expand 7.5X by 2030, Finds New Study by Fact.MR
In recent years, increasing popularity of OLED TVs in China and India has been significantly influencing growth of the mini LED market. With an increase in disposable income of a majority of the population in these countries, the inclination towards smart screens with higher lifespan and better performance is expected to open up numerous growth opportunities for the mini LED market. Moreover, aspiring and affluent households have increased their spending
Uncertainty Surrounding COVID-19 to Shave-off Growth in Electrical Steel Market …
The global electrical steel market has utilized the opportunities in the market over the last decade with sales of electrical steel pegged at US$ 20.4 Bn in 2019. However, sales are set to plummet during in the middle two quarters of 2020 owing to COVID-19. In addition, several automakers have shuttered their production units, causing incalculable loss to the electrical steel market in 2020. However, the demand of electrical steel
Medical Device Contract Manufacturing Market Set for Strong Growth, Production F …
The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated